InNexus Financial Statements From 2010 to 2026
| IXSBFDelisted Stock | USD 0.0001 0.00 0.00% |
Check InNexus Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among InNexus Biotechnology's main balance sheet or income statement drivers, such as , as well as many indicators such as . InNexus financial statements analysis is a perfect complement when working with InNexus Biotechnology Valuation or Volatility modules.
InNexus |
InNexus Biotechnology Company Shares Outstanding Analysis
InNexus Biotechnology's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current InNexus Biotechnology Shares Outstanding | 163.2 M |
Most of InNexus Biotechnology's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, InNexus Biotechnology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, InNexus Biotechnology has 163.2 M of shares currently outstending. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The shares outstanding for all United States stocks is notably lower than that of the firm.
InNexus Biotechnology Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining InNexus Biotechnology's current stock value. Our valuation model uses many indicators to compare InNexus Biotechnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across InNexus Biotechnology competition to find correlations between indicators driving InNexus Biotechnology's intrinsic value. More Info.InNexus Biotechnology is currently regarded as number one stock in return on asset category among its peers. It also is considered the number one company in current valuation category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value InNexus Biotechnology by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About InNexus Biotechnology Financial Statements
InNexus Biotechnology stakeholders use historical fundamental indicators, such as InNexus Biotechnology's revenue or net income, to determine how well the company is positioned to perform in the future. Although InNexus Biotechnology investors may analyze each financial statement separately, they are all interrelated. For example, changes in InNexus Biotechnology's assets and liabilities are reflected in the revenues and expenses on InNexus Biotechnology's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in InNexus Biotechnology. Please read more on our technical analysis and fundamental analysis pages.
InNexus Biotechnology, Inc., a development stage company, engages in the commercialization of monoclonal antibodies based on its Dynamic Cross Linking technology. InNexus Biotechnology, Inc. is headquartered in Vancouver, Canada. Innexus Biotechnology is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in InNexus Stock
If you are still planning to invest in InNexus Biotechnology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the InNexus Biotechnology's history and understand the potential risks before investing.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |